3 weeks ago
Novo Nordisk Taps AWS as Preferred Cloud and AI Partner
A very big medicine company called Novo Nordisk and a computer company called Amazon Web Services decided to work together.
They want computers to help find new medicines faster.
Finding new medicines is hard work, because scientists have to test many tiny things to see which ones might help sick people.
The two companies will put their smart workers together in a special place in London.
There, scientists and computer experts will work side by side instead of waiting for each other.
The computers will help figure out which medicines might work best.
Novo Nordisk says more than 25,000 of its workers already use these clever computer tools.
Amazon will be Novo Nordisk's favorite cloud and AI helper.
Together, they hope new medicines will reach patients much sooner.
But making a medicine still takes many tests and safety checks before it can help people.
AWS will become Novo Nordisk's preferred cloud provider and strategic AI partner under a partnership announced on August 10.
The companies are setting up a co-innovation hub at Novo Nordisk's King's Cross facility in London.
More than 25,000 Novo Nordisk employees already use AI tools built with Amazon Bedrock.
Novo Nordisk will use AWS technologies including Amazon Bio Discovery, Amazon Bedrock and Bedrock AgentCore.
The companies aim to shorten the journey from identifying a drug target to the first human dose.
- Who
- Novo Nordisk, led by CEO Mike Doustdar, and Amazon Web Services, led by CEO Matt Garman.
- What
- A strategic partnership making AWS Novo Nordisk's preferred cloud provider and AI partner, including a co-innovation hub for AI-driven drug discovery.
- Where
- At Novo Nordisk's King's Cross facility in London; the company operates across 80 countries.
- When
- Announced on August 10.
- Why
- To bring AI deeper into research and development, accelerate discovery, and compress drug discovery timelines.
Key facts
- Announcement date
- August 10
- AWS role
- Preferred cloud provider and strategic AI partner
- Co-innovation hub
- King's Cross facility, London
- Employees using AI tools
- More than 25,000
- AWS technologies
- Amazon Bio Discovery, Amazon Bedrock, Bedrock AgentCore
- Novo Nordisk workforce
- More than 66,700 people across 80 countries
- Previous AI work
- Assessed one billion virtual molecules; screened about 2,500 compounds
- Existing Amazon relationship
- Amazon Pharmacy, Amazon Ads, Amazon One Medical
Quotes
Novo Nordisk CEO Mike Doustdar
Chief Executive Officer of Novo Nordisk
“the partnership was about making AI “a driver of innovation” across the company, adding that the company was using it to accelerate discovery and develop AI solutions for people living with serious chronic diseases.”
easterneye.biz
“the partnership would combine the company's technology with Novo Nordisk's scientific expertise to help “compress drug discovery timelines” and process complex datasets securely.”
easterneye.biz
Sources
Related news
Claude Produces Working Binders for 14 of 15 Drug Targets
International Conference on AI-Driven Drug Development Begins in Indore
AWS and Nvidia Plan Two Million More AI GPUs
India’s Pharma Industry Embraces AI Amid Regulatory Concerns
UPSC GS-3 Practice Examines UPI Sustainability and AI Drug Discovery
